Everolimus-Eluting Platinum Chromium Coronary Stent System
SYNTAX II: CABG-LIKE OUTCOMES WITH SYNERGY™ BP STENT AND STATE-OF-THE-ART PCI STRATEGY
The 12 month results were then compared to the PCI and CABG arms of the original SYNTAX I Trial as historical comparators. So what did we learn?
We learned that contemporary CTO PCI in SYNTAX II Trial demonstrated a significantly higher procedural success rate compared to those in SYNTAX I.
PCI with CTO procedural success rates jumped from 53% in SYNTAX I to 87% in SYNTAX II. That represents a 64% increase in successful CTO treatment.
We learned that SYNERGY™ BP-EES together with other contemporary technologies and techniques proved PCI could be an option for patients with complex three-vessel disease.
Low rates of revascularization, peri-procedural MI and acute ST suggest that SYNERGY BP-EES might help in reducing procedural related complications.
We learned that IVUS helps to optimize stent placement and achieve better outcomes when used as a part of contemporary PCI.
Post-Implantation IVUS was performed in 84% of patients leading to further stent optimization in 30% of lesions.